Summit Therapeutics Inc vs SoundHound AI Inc — how do they compare? Summit Therapeutics Inc trades at $14.57 (market cap $10.48B), while SoundHound AI Inc trades at $6.56 (market cap $2.75B). The key difference: Summit Therapeutics Inc is far larger — about 3.8× SoundHound AI Inc's market cap. Which is the better fit depends on your goals.
| SMMT | SOUN | |
|---|---|---|
Market Cap | $10.48B | $2.75B |
Sector | Health | Technology |
52-Week High | $29.32 | $21.40 |
52-Week Low | $13.05 | $5.90 |
Enterprise Value | $9.90B | $2.54B |
Trailing returns across standard periods
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →